Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

AllianzGI Health Sciences Fund

+ Add to Watchlist

RBGHX:US

28.78 USD 0.27 0.95%

As of 09:29:30 ET on 01/29/2015.

Snapshot for AllianzGI Health Sciences Fund (RBGHX)

Year To Date: +3.82% 3-Month: +6.21% 3-Year: +24.06% 52-Week Range: 22.57 - 29.13
1-Month: +2.71% 1-Year: +25.69% 5-Year: +18.77% Beta vs MXWO0HC: 1.10

Mutual Fund Chart for RBGHX

No chart data available.
  • RBGHX:US 28.78
  • 1M
  • 1Y
Interactive RBGHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RBGHX

AllianzGI Health Sciences Fund is open-end fund incorporated in the USA. The Fund seeks long-term capital appreciation. The Fund invests in the equity securities of health care companies of any size located in at least three different countries, which may include the United States.

Inception Date: 02-05-2002 Telephone: 1-888-852-3922
Managers: MICHAEL DAUCHOT / JOHN SCHROER
Web Site: www.allianzinvestors.com

Fundamentals for RBGHX

NAV (on 2015-01-29) 28.78
Assets (M) (on 2014-12-31) 183.37
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for RBGHX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-11) 2.98
Dividend Yield (ttm) 17.23

Fees & Expenses for RBGHX

Front Load 0.00
Back Load 5.00
Current Mgmt Fee 1.20
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.21

Top Fund Holdings for RBGHX

Filing Date: 10/31/2014
Name Position Value % of Total
Gilead Sciences Inc 71,170 7,971,040 4.507%
Actavis plc 32,470 7,881,768 4.457%
Mallinckrodt PLC 76,915 7,090,025 4.009%
Johnson & Johnson 64,605 6,963,127 3.937%
Roche Holding AG 23,400 6,905,372 3.905%
Celgene Corp 57,270 6,133,044 3.468%
Vertex Pharmaceuticals Inc 54,274 6,113,423 3.457%
HCA Holdings Inc 77,140 5,403,657 3.055%
Shire PLC 80,025 5,369,432 3.036%
Boston Scientific Corp 387,950 5,151,976 2.913%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil